Abstract
We have developed an enzyme-linked immunosorbent assay (ELISA) for the measurement of antibodies reactive with a 98 amino acid fragment, called D1, of a recombinant thyroid and eye muscle membrane protein corresponding to a MW of 64 kDa (called 1D) in the serum of patients with thyroid autoimmunity with and without ophthalmopathy. Antibodies against the D1 fragment expressed as a fusion protein with β galactosidase, were detected in 29% of patients with thyroid-associated ophthalmopathy (TAO) of <1 yr duration, in 33% of those with disease of >3 yr duration, in 40% of patients with Graves’ hyperthyroidism (GH) without evident eye disease, in 31% of patients with lid lag and retraction but no other signs of progressive ophthalmopathy, in 25% of patients with euthyroid Graves’ disease and in 43% of patients with untreated Hashimoto’s thyroiditis (HT), but in none of 14 patients with other (non-immunological) thyroid disorders. Although tests were positive in 6 out of the 15 patients with ophthalmopathy and no overt thyroid autoimmunity overall there was no close association of the antibodies with clinical features of the eye disease or its course. In those sera in which Western blotting for antibodies reactive with a 64 kDa eye muscle membrane protein and ELISA were both carried out there was no close correlation between the two tests. In order to better understand the significance of antibodies reactive with 64 kDa eye muscle and thyroid membrane autoantigens and their possible relationship to ophthalmopathy it will be necessary to perform prospective studies of patients with untreated Graves’ hyperthyroidism beginning before the onset of eye signs, using antibody assays incorporating full length recombinant proteins.
Similar content being viewed by others
References
Kodama K., Sikorska H., Bandy-Dafoe P., Bayly R., Wall J.R. Demonstration of a circulating autoantibody against a soluble eye muscle antigen in Graves’ ophthalmopathy. Lancet 2: 1353, 1982.
Mengistu M., Laryea E.A., Miller A., Wall J.R. Clinical significance of a new autoantibody against a human eye muscle soluble antigen detected by immunofluorescence. Clin. Exp. Immunol. 65: 19, 1986.
Miller A., Sikorska H., Salvi M., Wall J.R. Evaluation of an enzyme-linked immunosorbent assay for the measurement of autoantibodies against eye muscle membrane antigens in Graves’ ophthalmopathy. Acta Endocrinol. (Copenh.) 113: 514, 1986.
Salvi M., Bernard N., Miller A., Zhang Z-G., Gardini E., Wall J.R. Prevalence of antibodies reactive with a 64 kDA eye muscle membrane antigen in thyroid-associated ophthalmopathy. Thyroid 1: 207, 1991.
Salvi M., Miller A., Wall J. Human orbital tissue and thyroid membranes express a 64 kDa protein which is recognized by autoantibodies in serum of patients with thyroid-associated ophthalmopathy. FEBS Lett 232: 135, 1988.
Atkinson S., Holcombe M., Kendall-Taylor P. Ophthalmopathic immunoglobulin in patients with Graves’ ophthalmopathy. Lancet 2: 374, 1984.
Faryna M., Nauman T., Gardas A. Measurement of autoantibodies against human eye muscle plasma membranes in Graves’ ophthalmopathy. Br. Med. J. 290: 454, 1985.
Ahman A., Baker J.R., Weetman A.P., Wartofsky L., Kretman T.B., Burman K.D. Antibodies to porcine eye muscle in patients with Graves’ ophthalmopathy: Identification of serum immunoglobulins directed against determinants by immunoblotting and eyzyme-linked immunoabsorbent assay. J. Clin. Endocrinol. Metab. 64: 454, 1989.
Kendall-Taylor P., Petros P. Circulating retrobulbar antibodies in Graves’ ophthalmopathy. Acta Endocrinol. (Copenh.) 121 (Suppl 2.): 31, 1989.
Kendler D.L., Rootman J., Huber K., Davis T.F. A 64 kDa membrane antigen is a recurrent epitope for natural autoantibodies in patients with Graves’ thyroid and ophthalmic diseases. Clin. Endocrinol. (Oxf.) 35: 539, 1991.
Hiromatsu Y., Sato M., Tanaka K., Shoji S., Nonaka K., Chinami M., Fukazawa H. Significance of anti-eye muscle antibody in patients with thyroid-associated ophthalmopathy by quantitative Western blot. Autoimmunity. 14: 1, 1993.
Zhang Z-G., Salvi M., Miller A., Bernard N., Arthurs B., Wall J.R. Restricted tissue reactivity of autoantibodies to a 64 kDa eye muscle membrane antigen in thyroid-associated ophthalmopathy. Clin. Immunol. Immunopathol. 62: 183, 1992.
Wang P.W., Hiromatsu Y., Laryea E.A., Wosu L., How J., Wall J.R. Immunologically mediated cytotoxicity against human eye muscle cells in Graves’ ophthalmopathy. J. Clin. Endocrinol. Metab. 63: 316, 1986.
Hiromatsu Y., Fukazawa H., Guinard F., Salvi M., How J., Wall J. A thyroid cytotoxic antibody that cross-reacts with an eye muscle cell surface antigen may be the cause of thyroid-associated ophthalmopathy. J. Clin. Endocrinol. Metab. 67: 565, 1988.
Elisei R., Dong Q., Weightman D., Ludgate M. Cloning and sequencing of candidate eye muscle antigens in Graves’ ophthalmopathy. In “Proc. 10th International Thyroid Congress The Hague, Netherlands” p. 166 Feb. 1991 (abstract).
Dong Q., Ludgate M., Vassart G. Cloning and sequencing of a novel 64 kDa autoantigen recognized by patients with autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 72: 1375, 1991.
Wall J.R., Bernard N., Boucher A., Salvi M., Kennerdell J., Tyutyunikov A., Genovese C. Pathogenesis of thyroid-associated ophthalmopathy; an autoimmune disorder of the eye muscle associated with Graves’ hyperthyroidism and Hashimoto’s thyroiditis. Clin. Immunol. Immunopathol. 68: 1, 1993.
Zhang Z-G., Dong Q., Rodien P., Alcade L., Bernard N., Boucher A., Vassart G.M., Ludgate M., Wall J.R. Autoantibodies in the serum of patients with autoimmune thyroid disorders react with a recombinant 98 amino acid fragment of a 64 kDa eye muscle recombinant protein which is also expressed in the thyroid. Autoimmunity 13: 151, 1992.
Salvi M., Zhang Z-G., Haegert D., Woo M., Liberman A., Cadarso L., Wall J. Patients with endocrine ophthalmopathy not associated with overt thyroid disease have multiple thyroid immunological abnormalities. J. Clin. Endocrinol. Metab. 70: 89, 1990.
Laemmli U.K. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227: 680, 1970.
Feldon S.E., Levin L. Graves’ ophthalmopathy V: Aetiology of upper eyelid retraction in Graves’ ophthalmopathy. Br. J. Ophthalmol. 74: 484, 1990.
Miller A., Arthurs B., Boucher A., Liberman A., Bernard N., Salvi M., Wall J.R. Significance of antibodies reactive with a 64 kDa eye muscle membrane antigen in patients with thyroid autoimmunity. Thyroid 2: 197, 1992.
Boucher A., Bernard N., Zhang Z-G., Salvi M., Rodien P., Triller H., Wall J.R. Nature and significance of orbital autoantigens and their corresponding autoantibodies in thyroid-associated ophthalmopathy. Autoimmunity 13: 89, 1992.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wall, J.R., Triller, H., Boucher, A. et al. Antibodies reactive with an intracellular epitope of a recombinant 64 kDa thyroid and eye muscle protein in patients with thyroid autoimmunity and ophthalmopathy. J Endocrinol Invest 16, 863–868 (1993). https://doi.org/10.1007/BF03348946
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348946